PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 78 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $485,000 | +7.8% | 60,330 | 0.0% | 0.09% | +3.4% |
| Q1 2018 | $450,000 | +22.0% | 60,330 | -2.7% | 0.09% | +27.5% |
| Q4 2017 | $369,000 | -20.0% | 62,010 | -1.1% | 0.07% | -24.2% |
| Q3 2017 | $461,000 | -6.5% | 62,670 | -12.9% | 0.09% | -3.2% |
| Q2 2017 | $493,000 | -0.8% | 71,930 | +36.7% | 0.09% | -6.0% |
| Q1 2017 | $497,000 | +9.5% | 52,600 | 0.0% | 0.10% | +4.2% |
| Q4 2016 | $454,000 | +34.3% | 52,600 | -1.5% | 0.10% | +29.7% |
| Q3 2016 | $338,000 | +42.6% | 53,410 | -5.1% | 0.07% | +42.3% |
| Q2 2016 | $237,000 | -4.4% | 56,260 | -1.0% | 0.05% | -5.5% |
| Q1 2016 | $248,000 | -28.7% | 56,800 | -0.1% | 0.06% | -30.4% |
| Q4 2015 | $348,000 | +5.5% | 56,850 | -1.4% | 0.08% | +3.9% |
| Q3 2015 | $330,000 | -23.4% | 57,660 | -0.2% | 0.08% | -9.5% |
| Q2 2015 | $431,000 | +25.3% | 57,780 | +0.5% | 0.08% | +27.3% |
| Q1 2015 | $344,000 | -23.6% | 57,480 | -3.5% | 0.07% | -27.5% |
| Q4 2014 | $450,000 | +24.3% | 59,550 | -14.6% | 0.09% | +13.8% |
| Q3 2014 | $362,000 | +281.1% | 69,700 | +215.4% | 0.08% | +300.0% |
| Q2 2014 | $95,000 | +21.8% | 22,100 | +16.3% | 0.02% | +11.1% |
| Q1 2014 | $78,000 | -27.1% | 19,000 | -5.0% | 0.02% | -33.3% |
| Q4 2013 | $107,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|